Neurofibromatosis type 1 and optic pathway glioma: A long-term follow-up

Minerva Pediatrica

Volumn 59, Issue 1, 2007, Pages 13-21

  Lama, G ^a,c   Esposito Salsano, M ^a   Grassia, C ^a   Calabrese, E ^a   Grassia, M G ^b   Bismuto, R ^a   Melone, M A B ^a   Russo, S ^a   Scuotto, A ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c NONE   (Italy)

Author keywords

Neurofibromatosis type 1; Neuroimaging; Optic nerve glioma

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC CHIASM; OPTIC NERVE GLIOMA; OUTCOME ASSESSMENT; PREVALENCE;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INTRACRANIAL HYPERTENSION; MAGNETIC RESONANCE IMAGING; MALE; NEUROFIBROMATOSIS 1; OPTIC CHIASM; OPTIC NERVE GLIOMA; PREVALENCE; REMISSION, SPONTANEOUS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TIME FACTORS; VISUAL PATHWAYS;

EID: 34247471661     PISSN: 00264946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Riccardi VM. Type 1 neurofibromatosis and the pediatric patient. Curr Probl Pediatr 1992;22:66-106.
2. Listernick R, Charrow J. Neurofibromatosis type 1 in childhood. J Pediatr 1990;16:845-51.
3. Xu G, O'Connell P, Viskochil D, Cawthon R, Robertson M, Culver M et al. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 1990;62:599-608.
4. Lama G, Grassia C, Avino G, Esposito Salsano M, Calabrese E, Tarallo MR et al. La neurofibromatosi tipo 1 in età pediatrica: 10 anni di esperienza. Riv Ital Pediatr 1998;24:99-107.
5. Listernick R, Charrow J, Gutmann D. Intracranial gliomas in Neurofibromatosis type 1. Am J Med Genet 1999;89:38-44.
6. Cummings TJ, Provenzale JM, Huntre SB, Friedman AH, Klintworth GK, Bigner Sh et al. Gliomas of the optic nerve: histological, immunohistochemical (MIB-1 and p53) and MRI analysis. Acta Neuropathol 2000;99:563-70.
7. Guillamo JS, Creange A, Kalifa C, Grill J, Rodriguez D, Doz F et al. Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1). A retrospective study of 104 patients. Brain 2003;126:152-60.
8. Listernick R, Charrow J, Greenwald MJ, Esterly NB. Optic gliomas in children with neurofibromatosis type 1. J Pediatr 1989;114:788-92.
9. Ng YT, North KN. Visual-evoked potentials in the assessment of optic gliomas. Pediatr Neurol 2001;24: 44-8.
10. Perilongo G, Moras P, Carollo C, Battistella A, Clementi M, Laverda A et al. Spontaneous partial regression of low-grade glioma in children with neurofibromatosis-1: a real possibility. J Child Neurol 1999;14:352-6.
11. Listernick R, Charrow J, Greenwald MJ. Emergence of optic pathway gliomas in children with neurofibromatosis type 1 after normal neuroimaging results. J Pediatr 1992;121:584-7.
12. Massry GG, Morgan CF, Chung SM. Evidence of optic pathway gliomas after previously negative neuroimaging. Ophthalmology 1997;104:930-5.
13. Listernick R, Louis DN, Packer RJ, Gutmann DH. Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force. Ann Neurol 1997;41:143-9.
14. Blazo MA, Lewis RA, Chintagumpala MM, Frazier M, McCluggage C, Plon SE. Outcomes of systematic screening for optic pathway tumors in children with Neurofibromatosis Type 1. Am J Med Genet A 2004;127: 224-9.
15. National Institutes of Health (NIH) Consensus Development Conference: Neurofibromatosis. Neurofibromatosis 1988;1:172-8.
16. Shuper A, Horev G, Kornreich L, Michowiz S, Weitz R, Zaizov R et al. Visual pathway glioma: an erratic tumor with therapeutic dilemma. Arch Dis Child 1997;76:259-63.
17. Packer RJ, Lange B, Ater J, Nicholson HS, Allen J, Walker R et al. Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood. J Clin Oncol 1993;11:850-6
18. Benzécri JP. Sur le calcul des taux d'inertie dans l'analyse d'un questionnaire. Cah Anal Donnees 1979; 4:377-8.
19. Benzécri JP. L'Analyse des données. Paris: Dunod; 1973.
20. Greenacre M. Theory and applications of correspondence analysis. London: Academic Press; 1992.
21. Signorini M, Zuccoli G, Ferrari F, Bacchini E, Street ME, Piazza P et al. Magnetic resonance findings and ophthalmologic abnormalities are correlated in patients with neurofibromatosis type 1 (NF1). Am J Med Genet 2000;93:269-72.
22. Iannaccone A, McCluney RA, Brewer VR, Spiegel PH, Taylor JS, Kerr NC et al. Visual evoked potentials in children with neurofibromatosis type 1. Doc Ophthalmol 2002;105:63-81.
23. Listernick R, Charrow J, Greenwald MJ, Mets M. Natural history of optic pathway tumors in children with neurofibromatosis type 1: a longitudinal study. J Pediatr 1994;125:63-6.
24. Grill J, Laithier V, Rodriguez D, Raquin MA, Kahn AP, Kalifa C. When do children with optic pathway tumours need treatment? An oncological perspective in 106 patients treated in a single centre. Eur J Pediatr 2000;159:692-6.
25. Szudek J, Friedman JM. Unidentified bright objects associated with features of neurofibromatosis 1. Pediatr Neurol 2002;27:123-7.
26. Singhal S, Birch JM, Kerr B, Lashford L, Evans DG. Neurofibromatosis type 1 and sporadic optic gliomas. Arch Dis Child 2002;87:65-70.
27. Thiagalingam S, Flaherty M, Billson F, North K. Neurofibromatosis type1 and optic pathway gliomas: follow-up of 54 patients. Ophthalmology 2004;111:568-77.
28. Tow SL, Chandela S, Miller NR, Avellino AM. Long-term outcome in children with gliomas of the anterior visual pathway. Pediatr Neurol 2003;28:262-70.
29. Gottschalk S, Tavakolian R, Buske A, Tinschert S, Lehmann R. Spontaneous remission of chiasmatic/ hipotalamic masses in Neurofibromatosis type 1: report of two cases. Neuroradiology 1999;41:199-201.
30. Sigorini M, Zuccoli G, Ferrozzi F, Bacchini E, Street ME, Piazza P et al. Magnetic resonance findings and opthalmologic abnormalities are correlated in patients with neurofibromatosis type 1 (NF1). Am J Med Genet 2000;93:269-72.